Who is sponsoring NCT05361642?

NCT05361642 is sponsored by Ain Shams University.

What drugs are being tested in NCT05361642?

Interventions in NCT05361642: Bupivacaine HCl 0.5% Injectable Solution, Dexmedetomidine.

Is NCT05361642 still recruiting?

NCT05361642 is currently status unknown. Last updated 2 September 2022.

Last reviewed 2022-09-02 · How we verify

NCT05361642

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Regional Nasal Block and Dexmedetomidine in Endoscopic Sinus Surgery

Status unknown NA Last updated 2 September 2022

What this trial tests

NA trial testing Bupivacaine HCl 0.5% Injectable Solution in Drug Use in 70 participants. Status unknown.

Timeline

3 February 2022

Primary endpoint
5 November 2022

5 December 2022

Quick facts

Lead sponsor	Ain Shams University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	70
Start date	3 February 2022
Primary completion	5 November 2022
Estimated completion	5 December 2022
Sites	1 location across Egypt

Drugs / interventions tested

Bupivacaine HCl 0.5% Injectable Solution — full drug profile →
Dexmedetomidine (dexmedetomidine) — full drug profile →

Conditions studied

Drug Use — all drugs for Drug Use →

Sponsor

Ain Shams University

Who can join

Adults 18 to 65, any sex, with Drug Use. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose is to compare the efficacy of combined regional nasal block and general anesthesia versus general anesthesia with dexmedetomidine during endoscopic sinus surgery in optimizing intraoperative surgical field.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Bupivacaine HCl 0.5% Injectable Solution

Trials testing the same drug.

NCT07216820 — Interscalene vs Phrenic-sparing Blocks in Obesity and Effect of Maximum Inspiratory Pressure · NA · recruiting
NCT05316168 — Post Operative Pain Management for ACL Reconstruction · Phase 3 · unknown
NCT05751421 — Pain Relief After PrimaryTKA · Phase 3 · unknown
NCT04784104 — Comparison of Infraclavicular And Supraclavicular Block · Phase 4 · unknown
NCT04756050 — Comparison of Different Approaches for Supraclavicular Block and Their Effects on Diaphragm Muscle Function · Phase 4 · completed

Other recruiting trials for Drug Use

Currently open trials in the same condition.

NCT07326748 — Lakota Family Acceptance Project · NA · recruiting
NCT05776316 — Harm Reduction Services · NA · recruiting
NCT06498167 — Active Pharmacovigilance Study of the Medicine Rinvoq™ (Upadacitinib) · recruiting
NCT05380765 — Developing a Positive Approach to Substance Use Prevention in North American Indian Adolescents · NA · recruiting
NCT06405490 — NALIRI-XELOX+AK104 for First-line Treatment of Advanced PDAC · Phase 2 · recruiting

Other Ain Shams University trials

Trials by the same sponsor.

NCT07435493 — Fentanyl Versus Opioid Free Multimodal Analgesia for Perioperative Pain Control in Children With Mild to Moderate Obstru · NA · not yet recruiting
NCT07482540 — Role of Dexmedatomidine Drug in Prevention of Atrial Fibrillations Post Mitral Valve Surgery · NA · not yet recruiting
NCT07531030 — Posterior Pericapsular Deep Gluteal Block Combined With Pericapsular Nerve Group and Lateral Femoral Cutaneous Nerve Blo · NA · not yet recruiting
NCT06839027 — Arterial to Central co2gap in Relation to Outcome After Cardiopulmonary Bypass · not yet recruiting
NCT07516535 — DISS vs FANS in Suction-Assisted RIRS for Medium-Sized Renal Stones · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05361642 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ain Shams University
Last refreshed: 2 September 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05361642.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing